National Institutes of Health Clinical Center (CC)
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, National Institutes of Health Clinical Center (CC) sits in the top decile of US sponsors by registered trial count (#107 of 15,742 sponsors by registered trial count).
National Institutes of Health Clinical Center (CC): 338 sponsored US clinical trials, 22 recruiting.
National Institutes of Health Clinical Center (CC) sponsors 338 registered US clinical trials on ClinicalTrials.gov, 22 of them currently recruiting, and 272 completed. 17 of these trials are in Phase 3-4 (later-stage) and 121 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 8 trials.
Top-decile sponsor footprint
National Institutes of Health Clinical Center (CC) ranks in the top decile of sponsors by registered trial count (#107 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
272 of 308 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
338 total, page 7 of 7
Magnetic Resonance Angiography (MRA) for the Diagnosis of Atherosclerosis
NCT00001841
Evaluation of Treated and Untreated Stroke
NCT00001840
A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome
NCT00001839
Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients
NCT00001837
Stereotactic Radiosurgery in Treating Patients With Brain Tumors
NCT00019578
Detection of Coronary Artery Calcification: Comparison of Volumetric and Electron Beam Computed Tomography
NCT00001836
PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
NCT00019565
Magnetic Resonance Imaging of Blood Flow in the Liver and Abdomen
NCT00001719
Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas
NCT00019513
Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
NCT00019604
Influences on HIV Infected Subjects' Willingness to Participate in Research and Ability to Give Informed Consent
NCT00001717
Effects of Nitric Oxide and Nitroglycerin in Patients With Sickle Cell Anemia
NCT00001716
Facilitation of Oral Bolus Propulsion Using Electropalatography in Patients With Dysphagia
NCT00001718
Evaluation of Patients With Blood Disorders
NCT00001715
Leucovorin for the Treatment of 5 q Minus Syndrome
NCT00004997
Magnetization Transfer Quantitation and Characterization for Clinical Scanners
NCT00001714
Magnetic Resonance Imaging (MRI) Ofl Volunteers
NCT00001711
Treatment for Blood Clots in the Veins of the Legs
NCT00001713
Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan
NCT00001712
Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy
NCT00001591
Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors
NCT00001589
The Early Reversibility of Rocuronium After Different Doses of Neostigmine
NCT00001520
Oxygen Uptake Kinetics During Recovery From Maximal and Submaximal Exercise
NCT00001519
Evaluating the Personal Computer as a Treatment Activity in Occupational Therapy
NCT00001516
A Randomized Evaluation of the Effect of Routine Normal Saline Flush Versus Heparinized Saline Solution in Groshong and Groshong PICC Catheters
NCT00001518
Diagnostic Effectiveness of Virtual Bronchoscopy
NCT00001515
Evaluation of Healthy Volunteer Marrow Donors Participating in the National Marrow Donor Program (NMDP)
NCT00001451
Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas
NCT00019019
Screening Study for the Department of Rehabilitation Medicine
NCT00023088
Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma
NCT00018954
Effects of Endotoxin in Normal Human Volunteers
NCT00001303
Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection
NCT00004850
Ultrasound and Videofluoroscopy for Diagnosing Swallowing Disorders
NCT00001220
Comparing Magnetic Resonance Imaging/Spectroscopy Techniques
NCT00001219
Development of Normative Ultrasound Databases of Tongue Surface Configuration
NCT00001218
NMR Scanning on Patients
NCT00001194
A Controlled Prospective Study of Transfusion-Associated Hepatitis
NCT00004848
Ultrasound Evaluation of Tongue Movements in Speech and Swallowing
NCT00001167
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 74 |
| Phase 2 | 47 |
| Phase 3 | 6 |
| Phase 4 | 11 |
Therapeutic Areas
What is open in the National Institutes of Health Clinical Center (CC) pipeline
22 recruiting of 338 indexed (7% open); 272 completed (80%).
Phase mix: 17 late (III/IV) vs 121 early (I/II) (early-phase heavy).
Top condition: Healthy (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
National Institutes of Health Clinical Center (CC): open-pipeline peers nationwide
Peers matched on 338 registered trials and 7% open enrollment, not the therapeutic-area sidebar.
National Institutes of Health Clinical Center (CC) sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 338 trials (± recruiting share)
- Cedars-Sinai Medical Center · 339 trials · 21% recruiting
- Ohio State University Comprehensive Cancer Center · 341 trials · 23% recruiting
- National Institute on Drug Abuse (NIDA) · 335 trials · 4% recruiting
- Children's Oncology Group · 342 trials · 10% recruiting
Sponsors near 7% open enrollment (± trial volume)
- Alliance for Clinical Trials in Oncology · 7% recruiting · 446 trials
- NICHD Neonatal Research Network · 7% recruiting · 61 trials
- Insmed Incorporated · 6% recruiting · 31 trials
- Baylor Breast Care Center · 7% recruiting · 15 trials
Related
What to do with this National Institutes of Health Clinical Center (CC) page
338 registered trials is a research-attention snapshot, not an endorsement of National Institutes of Health Clinical Center (CC) or any single study.
- 22 of National Institutes of Health Clinical Center (CC)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition National Institutes of Health Clinical Center (CC) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. National Institutes of Health Clinical Center (CC) pipeline card: 338 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.